Point72 Asia Singapore Pte. Ltd. lessened its stake in TrueBlue, Inc. (NYSE:TBI – Free Report) by 34.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 27,485 shares of the business services provider’s stock after selling 14,733 shares during the quarter. Point72 Asia Singapore Pte. Ltd. owned approximately 0.09% of TrueBlue worth $283,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Algert Global LLC acquired a new stake in shares of TrueBlue in the second quarter valued at approximately $208,000. Pacific Ridge Capital Partners LLC lifted its holdings in TrueBlue by 18.0% during the 2nd quarter. Pacific Ridge Capital Partners LLC now owns 48,961 shares of the business services provider’s stock valued at $504,000 after purchasing an additional 7,479 shares during the last quarter. Millennium Management LLC boosted its position in TrueBlue by 6.3% during the second quarter. Millennium Management LLC now owns 532,039 shares of the business services provider’s stock worth $5,480,000 after purchasing an additional 31,683 shares during the period. AQR Capital Management LLC increased its holdings in shares of TrueBlue by 7.5% in the second quarter. AQR Capital Management LLC now owns 333,100 shares of the business services provider’s stock valued at $3,431,000 after purchasing an additional 23,315 shares during the last quarter. Finally, Marshall Wace LLP raised its position in shares of TrueBlue by 330.7% in the second quarter. Marshall Wace LLP now owns 143,910 shares of the business services provider’s stock valued at $1,482,000 after purchasing an additional 110,495 shares during the period. 97.15% of the stock is owned by institutional investors.
TrueBlue Price Performance
Shares of TBI opened at $7.71 on Wednesday. The firm has a 50 day simple moving average of $8.48 and a two-hundred day simple moving average of $10.04. TrueBlue, Inc. has a one year low of $7.09 and a one year high of $16.14. The company has a market cap of $235.69 million, a P/E ratio of -20.84 and a beta of 1.50.
Wall Street Analyst Weigh In
TBI has been the subject of a number of research analyst reports. BMO Capital Markets decreased their target price on TrueBlue from $13.00 to $12.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. StockNews.com lowered TrueBlue from a “hold” rating to a “sell” rating in a report on Tuesday, August 6th.
Get Our Latest Stock Report on TrueBlue
About TrueBlue
TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.
Further Reading
- Five stocks we like better than TrueBlue
- 3 Warren Buffett Stocks to Buy Now
- Ready for Growth? Barrick Gold Stock Could Be the Answer
- What Do S&P 500 Stocks Tell Investors About the Market?
- Trade Like a Member of Congress With These 2 ETFs
- Insider Trading – What You Need to Know
- October’s Top 3 Stocks Revealed by MarketBeat’s MarketRank Tool
Receive News & Ratings for TrueBlue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TrueBlue and related companies with MarketBeat.com's FREE daily email newsletter.